From January 1, 2022 to March 31, 2022, the company has repurchased 653,900 shares, representing 1.45% for ¥1,282.85 million. With this, the company has completed the repurchase of 719,400 shares, representing 1.6% for ¥1,411.44 million under the buyback announced on November 4, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,086 JPY | +0.29% |
|
+3.01% | +3.42% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.42% | 581M | |
+16.80% | 43.26B | |
+17.47% | 21.6B | |
+21.73% | 15.93B | |
+23.95% | 15.1B | |
+57.96% | 12.95B | |
-0.05% | 6.79B | |
-16.22% | 6.29B | |
+21.38% | 6.04B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 4, 2021.